1Kidney Disease:Improving Global Outcomes(KDIGO) Glomeru- lonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis [ J ]. Kidney Inter Suppl, 2012,2 (2) : 139 - 274.
2Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology Guidelines for screening, treatment, and manage- ment of lupus nephritis[J]. Arthritis Care Res(Hoboken), 2012, 64(6) :797 - 808.
3Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association- European Dialysis and Transplant Association (EULAR/ERA- EDTA) recommendations for the management of adult and paediatric lupus nephritis[J]. Ann Rheum Dis,2012,71 (11 ) : 1 771 - 1 782.
4Gordon C. Pregnancy and autoimmune diseases [J]. Best Pract Res Clin Rheumatol, 2004,18 (3) : 359 - 379.
5Abarientos C, Sperber K, Shapiro DL, et al. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy [ J ]. Expert Opinion on Drug Safety, 2011,10 (5) : 705 - 714.
6Kwok LW, Tam LS, Zhu T, et al. Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythe- matosus [J ]. Lupus, 2011,20 (8) : 829 - 836.
